In vivo intra-tumoral electroporation of Gp96-Ig/Fc-OX4OL stimulates CD8+T cell cross-priming to tumor specific neoantigens

被引：0
|
作者：
de Silva, Suresh
Fromm, George
Haque, Jamil
Campbell, Jean S.
Pierce, Robert H.
Schreiber, Taylor H.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-567
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
567
引用
收藏
页数：4
相关论文
共 7 条
  • [1] Combined intratumoral electroporation and allogeneic vaccination of Gp96-Ig/Fc-OX40L stimulates CD8 T cell cross-priming to tumor specific neoantigens and enhanced anti-tumor response
    de Silva, Suresh
    Fromm, George
    Mukhopadhyay, Anandaroop
    Campbell, Jean
    Pierce, Robert
    Schreiber, Taylor
    CANCER RESEARCH, 2017, 77
  • [2] A novel TNFRSF25 agonist, PTX35, synergizes with Gp96-Ig/OX40L-Ig to enhance effector and memory anti-tumor CD8+T cell responses and delay tumor growth
    Tahiliani, Vikas
    Dillon, Patrick
    Miriyala, Jayalakshmi
    Trinh, Anh
    Jasuja, Rahul R.
    Hutchins, Jeff
    Seavey, Matthew M.
    CANCER RESEARCH, 2020, 80 (16)
  • [3] A novel TNFRSF25 agonist, PTX35, synergizes with Gp96-Ig/OX40-LIg to enhance effector and memory anti-tumor CD8+T cell responses and delay tumor growth
    Tahiliani, Vikas
    Dillon, Patrick
    Miriyala, Jayalakshmi
    Rose, Jason
    Anh Trinh
    Jasuja, Rahul
    Hutchins, Jeff
    Seavey, Matthew
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [4] Gp96-Ig/Costimulator (OX40L, ICOSL, or 4-1BBL) Combination Vaccine Improves T-cell Priming and Enhances Immunity, Memory, and Tumor Elimination
    Fromm, George
    de Silva, Suresh
    Giffin, Louise
    Xu, Xin
    Rose, Jason
    Schreiber, Taylor H.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (09) : 766 - 778
  • [5] Effect on anti-tumor immunity and long-term memory CD8+T-cell generation with a novel, allogeneic cell based, Gp96-Ig/OX40L cancer vaccine.
    Hutchins, Jeff
    Tahiliani, Vikas
    Miriyala, Jayalakshmi
    Rose, Jason
    Dillon, Patrick
    Seavey, Matthew M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells
    Nowak, AK
    Lake, RA
    Marzo, AL
    Scott, B
    Heath, WR
    Collins, EJ
    Frelinger, JA
    Robinson, BWS
    JOURNAL OF IMMUNOLOGY, 2003, 170 (10): : 4905 - 4913
  • [7] Combination immunotherapy: T-cell costimulation (OX40L, TL1A, 4-1BBL and ICOSL) secreted locally by Gp96-Ig vaccines, elicits robust antigen-specific, memory T cell responses and tumor elimination
    Fromm, George J.
    de Silva, Suresh
    Giffin, Louise
    Rose, Jason
    Goyal, Aditi
    Schreiber, Taylor H.
    CANCER RESEARCH, 2016, 76
1